Genscript Biotech Corporation
GNNSF | OTC
$4.50
$0.00 (0.00%)
At close: Oct 28, 2026, 9:30 AM ET
$4.50
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 5:00 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
39
+1.8 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #557/1028 (Top 54%)
Key Statistics
Market Data
Market Cap $10.12B
1D Range
4.50 4.50
52W Range
1.30 6.35
Valuation (TTM)
PE -15.52
PB 2.60
EV/EBITDA 48.09
Valuation (NTM)
Forward PE 56.73
Forward PEG 0.13
Price Target $0.00
Cash Flow
FCF Yield 0.5%
SBC Adj. FCF Yield 0.5%
SBC Impact -10.4%
Margins
Gross Margin 52.0%
Operating Margin 14.9%
FCF Margin 6.0%
Growth (CAGR)
Revenue 3Y | 5Y 38.5% |
53.6%
Dil EPS 3Y | 5Y -28.5% |
-45.9%
FCF 3Y | 5Y 91.4% |
22.8%
Returns
ROA -13.3%
ROE -16.2%
ROIC 3.0%
Financial Health
Net Cash
$537.94M
Current Ratio 1.48
Interest Coverage 8.67
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Genscript Biotech Corporation, an investment holding firm, operates on a global scale as a leading provider of life science research products and services, serving North America, Europe, China, Japan,...
Sector Healthcare
Industry Biotechnology
Employees 6,165
IPO Date Sep 28, 2017
Website www.genscript.com
Fiscal Year n/a
Latest News
3 months ago · seekingalpha.com
Genscript Biotech Corporation (GNNSF) Q2 2026 Earnings Call TranscriptGenscript Biotech Corporation (GNNSF) Q2 2026 Earnings Call Transcript
Add to Watchlist
Select watchlists to add or remove GNNSF